CRISPR-Based Gene Editing Techniques in Pediatric Neurological Disorders.

Area of Science:

• Genetics and Genomics
• Neurology
• Biotechnology

Background:

• Gene editing technologies present novel therapeutic avenues for pediatric neurological disorders.
• CRISPR-based systems offer specificity, versatility, and cost-effectiveness for personalized gene therapy.
• Current challenges include optimizing editing efficiency, minimizing off-target effects, and managing immune responses.

Purpose of the Study:

• To review the fundamentals of CRISPR-based gene therapies for pediatric neurological disorders.
• To discuss the opportunities and challenges associated with these emerging therapies.
• To highlight preclinical advancements in applying CRISPR to specific pediatric neurological diseases.

Main Methods:

• Review of current literature on CRISPR-Cas gene editing technologies.
• Analysis of preclinical studies focusing on pediatric neurological conditions.
• Discussion of the potential clinical applications, benefits, and risks of CRISPR-based therapies.

Main Results:

• CRISPR technology enables precise correction of dysfunctional mutations or modulation of gene expression.
• Significant preclinical progress has been made in various pediatric neurological diseases.
• Optimization of editing efficiency and safety profiles are critical for clinical translation.

Conclusions:

• CRISPR-based gene therapies hold immense promise for treating pediatric neurological disorders.
• Understanding the benefits and risks is crucial for clinicians.
• Further research and development are necessary to overcome existing challenges and enable widespread clinical use.